Social Responsibility

Awamedica and Corporate Social Responsibility

Background:

Awamedica’s first responsibility is to contribute to health care through the manufacturing and marketing of high quality pharmaceuticals.

Further to this Awamedica has a Corporate Social Responsibility Policy making it organise events, support different activities, take action and make plans and proposals to first of all the KRG authorities for the benefit of the Health Care System generally. These contributions are often based on Awamedica’s international network, notably with Sweden.

Contributions:

  1. The creation of an independent regulatory authority, the Kurdistan Medical Products Agency (KMCA), in 2006 was an initiative of Awamedica’s founder Dr.Bahram Resul, who organised the authority using plans and routines from the Swedish counterpart, the Medical Products Agency.
  1. Following an initiative by Awamedica, and working with KMCA, the Swedish Academy of Pharmaceutical Sciences in 2011 prepared a plan for a two week training of five KMCA inspectors in Sweden. The plan had both theoretical and practical parts including visits and training at Swedish pharmaceutical companies manufacturing plants.
  1. At the request of the organizers of “The International Congress on Reform and Development of the Health Care System in Kurdistan Region – Iraq” in 2011, Awamedica contributed with three speakers from Sweden.

Dr.Bertil Karlmark covered “Building a system for pharmacovigilance (side effect reporting) for the Kurdistan Region, Iraq” , Dr.Per Allan Örtenwall made a presentation about “Organizational aspects of emergency medicine” and Mr.Stellan Lind made a proposal for “A health care products procurement and distribution  system for Kurdistan”.

  1. Further to Dr.Karlmark’s presentation above a detailed plan and budget for the “Building of a system for Pharmacovigilance for KRG” was presented to KMCA. It included all details on training of doctors, pharmacists, and pharmaceutical company and government authority personnel as well as how to tie the system to the World Health Organization. The proposal was based on Dr.Karlmark’s successful building of such a system for Jordan, where it is up and running since 2003.
  1. On a regular basis pharmacy university students in KRG are invited to Awamedica to learn about pharmaceuticals manufacturing and also to use Awamedica’s laboratory resources for their work at the university.
  1. At the request of respective authorities, Awamedica is on a regular basis training personnel from the Ministries of Health in both KRG and Baghdad in quality control procedures, routines and documentation.
  1. Awamedica has since its start provided Peshmerga forces, as well as Peshmerga families, with free medicines. It has also done so to underprivileged families in different parts of Kurdistan.
  1. Awamedica is also the sole supplier to major Non-Governmental-Organizations such as Doctors Without Borders, Medair and IMC.
  1. To make sure that patients in Kurdistan fully understand how its products should be used, with indications, dosage and warnings, Awamedica includes Kurdish as one of  the languages in its package insert leaflets.
  1. Awamedica on a continuous basis acts as a sponsor of Kurdistan’s medical associations, their meetings and seminars.
  1. As a service to the medical community Awamedica’s website (www.awamedica.com) offers links to Swedish health care networks and research institutions. It also has links to Scandinavian and other leading international scientific journals.
  1. In November of 2015, as a first in a series, Awamedica organised a non-product related Scientific Symposium in cardiology in Erbil with two distinguished speakers from Sweden.

Professor Gunnar Nyberg lectured about Non-invasive determination of arterial elasticity, a new approach in judging the condition of the vascular system, important for diagnosis and treatment of heart diseases.

Professor Anders Waldenström lectured about Recent advances in the treatment of heart failure, and described front-line cardiology research results.

The Symposium was attended by some forty cardiologists from Erbil, Suleimanieh and Dohok, by ten students in medicine from University Kurdistan Hawler and their cardiology teachers, and also by representatives from Awamedica’s partner company Sanofi.

  1. The appreciation of Awamedica’s Social Responsibility efforts is well expressed in a 2015 letter from the Ministry of Health in Baghdad:

“In view of your high patriotism and active contribution in helping patients, we would like to express our deep gratitude and appreciation to your company and your staff, wishing you perpetual success and prosperity in serving our beloved country Iraq.”

 

2016-08-31